about
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several c...
Read More
109.65
-1.83
(-1.64%)
517.4K
XNAS Volume
XNAS 30 Jul, 2025 3:47 PM (EDT)
Board Meeting
The next board meeting for BioNTech SE - ADR is on 05 Aug 2025 for the purpose of BioNTech SE Second Quarter Earnings Results for 2025
See details
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
BioNTech SE - ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..